Reported about 1 year ago
Miss Chen, 33 years old, diagnosed with early triple-negative breast cancer, underwent neoadjuvant therapy and immunotherapy, stabilizing the condition without the need for a mastectomy. The aggressive nature of triple-negative breast cancer often leads to metastasis and high recurrence rates, making treatment challenging. Immunotherapy is now offering a solution by improving survival rates and reducing the risk of recurrence. Combining chemotherapy with immunotherapy after surgery has shown to enhance patient outcomes and prolong survival, aligning with international treatment guidelines to prevent disease relapse.
Source: YAHOO